Indication
Von Willebrand Disease
10 clinical trials
15 products
Product
ADVATEProduct
rVWFClinical trial
A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis With rVWF in Children Diagnosed With Severe Von Willebrand DiseaseStatus: Not yet recruiting, Estimated PCD: 2027-02-20
Clinical trial
A Phase 3b, Prospective, Open-Label, Uncontrolled, Multicenter Study on Long-Term Safety and Efficacy of rVWF in Pediatric and Adult Subjects With Severe Von Willebrand Disease (VWD)Status: Recruiting, Estimated PCD: 2025-03-31
Product
rFVIIIProduct
WilateClinical trial
Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With Von Willebrand Disease (VWD)Status: Completed, Estimated PCD: 2022-04-23
Product
Von Willebrand FactorClinical trial
A Prospective, Multicenter, Non-Interventional Study Evaluating the Bleeding Incidence in Patients With Von Willebrand Disease Undergoing On-Demand TreatmentStatus: Completed, Estimated PCD: 2021-01-31
Product
VGA039Clinical trial
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of VGA039 Following IV or SC Administration of Single Ascending Doses in Healthy Adults and Subcutaneous Adult Patients With Von Willebrand DiseaseStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
Prospective, Randomized, Crossover Trial Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women With Von Willebrand Disease: The VWD Minimize StudyStatus: Terminated, Estimated PCD: 2022-04-30
Product
Tranexamic acidClinical trial
Prospective, Randomized Trial Comparing Recombinant Von Willebrand Factor (rVWF) Plus Tranexamic Acid vs. rVWF Alone to Reduce Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN TrialStatus: Recruiting, Estimated PCD: 2024-08-01
Product
Tranexamic AcidClinical trial
A Multi-cEnter, Pilot, Crossover Trial of Prophylactic Wilate coMpared to PlacebO for Heavy Menstrual Bleeding in Patients With Von WillEbRand DiseaseStatus: Not yet recruiting, Estimated PCD: 2026-09-01
Clinical trial
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders StudyStatus: Not yet recruiting, Estimated PCD: 2028-12-01
Product
NorethindroneClinical trial
Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow ConditionsStatus: Recruiting, Estimated PCD: 2026-05-01
Product
Blood sampling